<p>Multiple Immune-Related Adverse Events and Anti-Tumor Efficacy: Real-World Data on Various Solid Tumors</p>

Keitaro Shimozaki, Yasutaka Sukawa, Noriko Beppu, +13

Cancer Management and Research

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors

Keitaro Shimozaki, Hideyuki Hayashi, Shigeki Tanishima, +10

Scientific Reports

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Yukie Hayashi, Naoki Hosoe, Kaoru Takabayashi, +15

Digestive Diseases and Sciences

Pathological CharacteristicsAutoimmune DiseaseImmunologyGastroenterologyPathology +7

Clinical Impact of Primary Tumor Location and<i>RAS, BRAF</i>V600E, and<i>PIK3CA</i>Mutations on Epidermal Growth Factor Receptor Inhibitor Efficacy as Third-line Chemotherapy for Metastatic Colorectal Cancer

Taro Sato, Hiroki Osumi, Eiji Shinozaki, +9

Anticancer Research

Analysis of Risk Factors for Immune-Related Adverse Events in Various Solid Tumors Using Real-World Data

Keitaro Shimozaki, Yasutaka Sukawa, Yasunori Sato, +9

Future Oncology

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis

Kohei Horiuchi, Shinnosuke Ikemura, Takashi Sato, +17

The Oncologist

Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer

Hiroki Osumi, Eiji Shinozaki, Akira Ooki, +8

Cancer Medicine

Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018

Izuma Nakayama, Daisuke Takahari, Keitaro Shimozaki, +8

The Oncologist

A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care

Keitaro Shimozaki, Izuma Nakayama, Daisuke Takahari, +8

ESMO Open

Prognostic EvaluationGastrointestinal OncologyAdvanced Gastric CancerMedicinePrognosis +8

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

Keitaro Shimozaki, Eiji Shinozaki, Noriko Yamamoto, +10

Journal of Cancer Research and Clinical Oncology

MedicineKras MutationGastroenterologyPathologyInsufficient Trastuzumab Efficacy +6